On August 3, 2018, at the Taiwan 2018 Latest Business Seminar in Tokyo, SNBL and Medgaea Life Sciences Ltd. (MDG) signed a Memorandum of Understanding (MOU). The MOU, signed by Dr. Chih-Chun Hong, Chief Executive Officer of MDG, and Koichiro Fukuzaki, Executive Vice Chairman of SNBL, confirms the intention of SNBL and MDG to collaborate more closely.
MDG was established in Taiwan in 2005 and offers a variety of pre-clinical contract research services for health foods, herbal medicine, medical devices, and chemical products. SNBL and MDG will promote and support R&D of drugs, medical devices, and regenerative medicine in Taiwan.
SNBL Japan will be attending the Eurotox 2018 in Brussels, September 2-5th. Email firstname.lastname@example.org to set up a meeting or visit Booth F to discuss how our diverse services can help your research.
SNBL has invested in Trunk Solution Corporation (TSC) and it has become an SNBL Group subsidiary company as of July 31, 2018.
TSC is a company that focuses research on the
best balanced posture. It markets science-supported health products including a patented wearable device to activate core muscles for those
This business partnership between SNBL and TSC will lead to improved health outcomes for many. This tie-up shows that SNBL Group is committed to freeing patients from suffering by supporting drug development and improving medical technology.
SNBL Japan is proud to sponsor the Global Scientist Award “Wings of Dreams”, a scientific poster and presentation contest for students from elementary to high school age.
The contest is accepting submissions from June to October, and posters will be presented in person on November 4th. The topics will be varied, from physics to biology and mathematics. There will also be a keynote address from a robotics expert, Dr. Takayuki Furuta.
Community is a big part of SNBL Japan’s philosophy so it is an honor to be involved in an event aimed at raising children who are interested in STEM (Science, Technology, Engineering, and Mathematics).
We are pleased to announce that Kengo Nishi has been awarded a diploma from the Japanese Society of Comparative and Veterinary Ophthalmology. Kengo is now a diplomate of the Japanese College of Fundamental Ophthalmologists.
Ocular toxicology is a burgeoning field and SNBL Japan is committed to having the right equipment and the right people to evaluate ocular toxicology. Kengo is the second diplomate of the Japanese College of Fundamental Ophthalmologists at SNBL Japan, and his skills will add to our safety assessment program. We look forward to seeing him use his skills in future.
We are proud to announce that Haruka Torihara, RDT has become a Japanese Teratology Society-approved Reproductive and Developmental Toxicologist. She joins the 6 other scientists who hold the RDT qualification at SNBL Japan.
The strength of SNBL’s DART program is thanks to the scientists who contribute to it. We are happy that Haruka’s contributions have been recognized and look forward to many more scientific contributions from her.
SNBL Japan received the Health & Productivity Award 2018, presented by the Japanese Ministry of Economy, Trade and Industry. This award recognizes organizations which promote health in their region by implementing strategies to improve the health and productivity of their employees.
As part of its strategy to improve employee health, SNBL Japan has implemented Wellness Tourism seminars, a series of health challenges, and early cancer screenings. SNBL Japan will strive to continue these efforts and ensure that the recognition of our strategy is meaningful.
We will host a joint exhibition with KOBE Biomedical Innovation Cluster at the 4th Regenerative Medicine Expo & Conference Japan held at INTEX Osaka on Wednesday, February 21 to Friday, February 23, 2018.
At the technical seminar on February 22, we will provide useful information to aid your cell/gene therapy R&D efforts. The presentation will introduce our preclinical services for evaluation of safety, tumorigenicity, biodistribution, and efficacy. We will also introduce our state-of-the-art technology in the ophthalmologic field. We are looking forward to your visit.
Click here for details.
Exhibition Title: 4th Regenerative Medicine Expo & Conference Japan
Dates: February 21 [Wed] - 23 [Fri], 2018
Venue: INTEX Osaka, Japan
Recently, Akiko Moriyama and Asami Urashima have passed the boards of the Japanese College of Veterinary Pathology. With the addition of these two pathologists, SNBL has 14 board-certified veterinary pathologists. Their dedication to their craft has helped improve our pathology program and deliver high quality results to our clients.
Congratulations, Akiko and Asami!
Thanks to the support of our valued clients and esteemed colleagues, SNBL Group celebrated its 60th anniversary on Saturday, September 16th, 2017. Since being founded in 1957 in Kagoshima, Japan, SNBL has gone on to expand around the world, and from preclinical testing all the way to innovative cancer treatment at our proton beam therapy center and resort. For the past 60 years we have been committed to freeing patients from suffering, by supporting drug development and improving medical technology. We hope to continue this important work over the next 6 decades, and to cement our place as Japan’s oldest and largest pre-clinical CRO.
We appreciate your continued support and hope to work with you as we continue to strive forward.
On September 13th, SNBL Japan received the 2017 Award for the Promotion of Women in Business, an award presented by Kagoshima Prefecture as part of the Plan for the Equality of Men and Women.
The award is presented to companies with a high number of women managers and employees, a low turnover rate for women, childcare leave for men, and good work-life balance. SNBL Japan was 1 of 3 companies to receive this award. SNBL Japan especially stood out in the turnover rate for women at 5.9%, an improvement of 5.2 points over the past 10 years. Parental leave and return to work after childbirth are considered to be an ordinary part of the company climate at SNBL.